Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
7.62
+0.15 (2.01%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Journey Medical Employees
Journey Medical had 41 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
41
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,369,122
Profits / Employee
-$357,854
Market Cap
175.13M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41 | 0 | - |
| Dec 31, 2023 | 41 | 21 | 105.00% |
| Dec 31, 2022 | 20 | -70 | -77.78% |
| Dec 31, 2021 | 90 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
DERM News
- 21 days ago - Top 3 Health Care Stocks That May Crash In Q2 - Benzinga
- 27 days ago - Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer - GlobeNewsWire
- 4 weeks ago - Journey Medical Corporation (DERM) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 5 weeks ago - Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea - GlobeNewsWire
- 5 weeks ago - Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025 - GlobeNewsWire
- 6 weeks ago - Journey Medical Corporation to Participate in the 37th Annual ROTH Conference - GlobeNewsWire
- 7 weeks ago - Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea - GlobeNewsWire